|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade receivables (net of allowance of $5,659 and $5,360, respectively) | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Advance royalties | ||||||||||||||||||||
| Digital assets | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, Plant and Equipment: | ||||||||||||||||||||
| Property, plant and equipment | ||||||||||||||||||||
| Less accumulated depreciation, depletion and amortization | ||||||||||||||||||||
| Total property, plant and equipment, net | ||||||||||||||||||||
| Other Assets: | ||||||||||||||||||||
| Advance royalties | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Debt securities | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Partners' Capital | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued taxes other than income taxes | ||||||||||||||||||||
| Accrued payroll and related expenses | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Workers' compensation and pneumoconiosis benefits | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Current maturities, long-term debt, net | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-Term Liabilities: | ||||||||||||||||||||
| Long-term debt, excluding current maturities, net | ||||||||||||||||||||
| Pneumoconiosis benefits | ||||||||||||||||||||
| Accrued pension benefit | ||||||||||||||||||||
| Workers' compensation | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Long-term operating lease obligations | ||||||||||||||||||||
| Deferred income tax liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Partners' Capital: | ||||||||||||||||||||
| ARLP Partners' Capital: | ||||||||||||||||||||
| Limited Partners - Common Unitholders 128,658,801 and 128,428,024 units outstanding, respectively | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total ARLP Partners' Capital | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total Partners' Capital | ||||||||||||||||||||
| Total Liabilities and Partners' Capital | ||||||||||||||||||||
Loading...
